TY - JOUR
T1 - Cardiovascular manifestation and treatment in COVID-19
AU - Su, Yen Bo
AU - Kuo, Ming Jen
AU - Lin, Ting Yu
AU - Chien, Chian Shiu
AU - Yang, Yi Ping
AU - Chou, Shih Jie
AU - Leu, Hsin Bang
N1 - Publisher Copyright:
Copyright © 2020, the Chinese Medical Association.
PY - 2020/8
Y1 - 2020/8
N2 - The novel coronavirus disease 2019 (COVID-19), with first presentation of atypical pneumonia, has spread rapidly from Wuhan, China, on December 12, 2019 to over 200 countries, caused 2 310 572 infected individuals and 158 691 mortalities, updated on April 19, 2020. Many studies have published timely to help global healthcare workers to understand and control the disease. Vulnerable patients with risk factors such as elderly, cardiovascular diseases (eg, hypertension, coronary disease, or cardiomyopathy), diabetes, and chronic kidney disease have worse outcomes after COVID-19 infection. COVID-19 could directly cause cardiovascular injuries such as pericarditis, myocarditis, myocardial infarction, heart failure, arrhythmias, or thromboembolic events, which urge cardiologists to be involved in the frontline to practice. Here, we provide a review of COVID-19 on cardiovascular system to assist clinical cardiologists to better understand the disease and being capable of providing comprehensive medical support.
AB - The novel coronavirus disease 2019 (COVID-19), with first presentation of atypical pneumonia, has spread rapidly from Wuhan, China, on December 12, 2019 to over 200 countries, caused 2 310 572 infected individuals and 158 691 mortalities, updated on April 19, 2020. Many studies have published timely to help global healthcare workers to understand and control the disease. Vulnerable patients with risk factors such as elderly, cardiovascular diseases (eg, hypertension, coronary disease, or cardiomyopathy), diabetes, and chronic kidney disease have worse outcomes after COVID-19 infection. COVID-19 could directly cause cardiovascular injuries such as pericarditis, myocarditis, myocardial infarction, heart failure, arrhythmias, or thromboembolic events, which urge cardiologists to be involved in the frontline to practice. Here, we provide a review of COVID-19 on cardiovascular system to assist clinical cardiologists to better understand the disease and being capable of providing comprehensive medical support.
KW - Cardiologists
KW - Cardiomyopathy
KW - Cardiovascular diseases
KW - COVID-19
UR - http://www.scopus.com/inward/record.url?scp=85086653631&partnerID=8YFLogxK
U2 - 10.1097/JCMA.0000000000000352
DO - 10.1097/JCMA.0000000000000352
M3 - Review article
C2 - 32433342
AN - SCOPUS:85086653631
SN - 1726-4901
VL - 83
SP - 704
EP - 709
JO - Journal of the Chinese Medical Association
JF - Journal of the Chinese Medical Association
IS - 8
ER -
